litlas
Log inCreate account

Richard Hubbard

Active 1996–2024

121
Papers
19,399
Citations
82
h-index
117
i10-index

Citations

Citations per year for Richard Hubbard1978: 1 citations1985: 1 citations1993: 1 citations1996: 1 citations1997: 2 citations1998: 3 citations1999: 3 citations2000: 20 citations2001: 39 citations2002: 34 citations2003: 53 citations2004: 77 citations2005: 108 citations2006: 117 citations2007: 146 citations2008: 158 citations2009: 149 citations2010: 133 citations2011: 175 citations2012: 164 citations2013: 190 citations2014: 191 citations2015: 182 citations2016: 186 citations2017: 180 citations2018: 220 citations2019: 529 citations2020: 650 citations2021: 589 citations2022: 409 citations2023: 325 citations2024: 466 citations2025: 200 citations2026: 2 citations1979–1984: no citations, so these years are not shown1986–1992: no citations, so these years are not shown1994–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,940 citing papers, 20.5% of this breakdownUnited Kingdom: 1,281 citing papers, 13.6% of this breakdownFrance: 504 citing papers, 5.3% of this breakdownChina: 501 citing papers, 5.3% of this breakdownItaly: 443 citing papers, 4.7% of this breakdownCanada: 421 citing papers, 4.5% of this breakdownGermany: 401 citing papers, 4.2% of this breakdownNetherlands: 354 citing papers, 3.7% of this breakdownAustralia: 350 citing papers, 3.7% of this breakdownSpain: 276 citing papers, 2.9% of this breakdownSweden: 245 citing papers, 2.6% of this breakdownDenmark: 216 citing papers, 2.3% of this breakdown
0%20.5%Other 26.7%

Institutions

Fields

  • Medicine80.4%
  • Biochemistry, Genetics and Molecular Biology8.7%
  • Immunology and Microbiology2.8%
  • Environmental Science2%
  • Health Professions1.4%
  • Neuroscience0.9%
  • Other3.8%

Topics

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis8.7%
  • Chronic Obstructive Pulmonary Disease (COPD) Research4.2%
  • Asthma and respiratory diseases3%
  • Sarcoidosis and Beryllium Toxicity Research2%
  • Systemic Sclerosis and Related Diseases1.6%
  • Occupational and environmental lung diseases1.5%
  • Other79%

Coauthors

All papers

Open in search
  1. Risk of Myocardial Infarction and Stroke after Acute Infection or Vaccination

    Authors: Liam Smeeth, Sara L. Thomas, Andrew Hall, Richard Hubbard, Paddy Farrington, Patrick Vallance - New England Journal of Medicine 2004 cited by 1,375

  2. Increased Risk of Myocardial Infarction and Stroke Following Exacerbation of COPD

    Authors: Gavin C. Donaldson, John R. Hurst, Christopher J. Smith, Richard Hubbard, Jadwiga A. Wedzicha - CHEST Journal 2009 cited by 518

  3. Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis

    Authors: Richard J. Allen, Beatriz Guillén‐Guío, Justin M. Oldham, Shwu‐Fan Ma, Amy Dressen, Megan L. Paynton, Luke M. Kraven, Ma’en Obeidat, Xuan Li, Michael Ng, Rebecca Braybrooke, María Molina‐Molina, Brian D. Hobbs, Rachel K. Putman, Phuwanat Sakornsakolpat, Helen Booth, William A. Fahy, Simon P. Hart, Mike Hill, Nik Hirani, Richard Hubbard, Robin J. McAnulty, Ann Millar, Vidya Navaratnam, Eunice Oballa, Helen Parfrey, Gauri Saini, Moira K. B. Whyte, Yingze Zhang, Naftali Kaminski, Ayodeji Adegunsoye, Mary E. Strek, Margaret Neighbors, Xuting R. Sheng, Gunnar Guðmundsson, Vilmundur Guðnason, Hiroto Hatabu, David J. Lederer, Ani Manichaikul, John D. Newell, George O'connor, Victor E. Ortega, Hanfei Xu, Tasha E. Fingerlin, Yohan Bossé, Ke Hao, Philippe Joubert, David C. Nickle, Don D. Sin, Wim Timens, Dominic Furniss, Andrew P. Morris, Krina T. Zondervan, Ian P. Hall, Ian Sayers, Martin D. Tobin, Toby M. Maher, Michael H. Cho, Gary M. Hunninghake, David A. Schwartz, Brian L. Yaspan, Philip L. Molyneaux, Carlos Flores, Imre Noth, Gísli Jenkins, Louise V. Wain - American Journal of Respiratory and Critical Care Medicine 2019 cited by 341

  4. In-Hospital Mortality after Surgical Lung Biopsy for Interstitial Lung Disease in the United States. 2000 to 2011

    Authors: John Hutchinson, Andrew Fogarty, Tricia M. McKeever, Richard Hubbard - American Journal of Respiratory and Critical Care Medicine 2015 cited by 442

  5. An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study

    Authors: Toby M. Maher, Eunice Oballa, Juliet K. Simpson, Joanne Porte, Anthony Habgood, William A. Fahy, Aiden Flynn, Philip L. Molyneaux, Rebecca Braybrooke, Hrushikesh Divyateja, Helen Parfrey, Doris M. Rassl, Anne‐Marie Russell, Gauri Saini, Elisabetta Renzoni, Anne-Marie R. Duggan, Richard Hubbard, Athol U. Wells, Pauline T. Lukey, Richard P. Marshall, Gísli Jenkins - The Lancet Respiratory Medicine 2017 cited by 275

  6. Vascular Factors and Risk of Dementia: Design of the Three-City Study and Baseline Characteristics of the Study Population

    Authors: Marilyn Antoniak, Maura Pugliatti, Richard Hubbard, John Britton, Stefano Sotgiu, A. Dessa Sadovnick, Irene M.L. Yee, Miguel A. Cumsille, Jorge A. Bevilacqua, Sarah Burdett, Lesley Stewart, Neil Pickering, Nino Khetsuriani, Eva S. Quiroz, Robert C. Holman, Larry J. Anderson, Rosalind Gait, Claire Maginnis, Sarah Lewis, Gustavo C. Román, Violeta Díaz, Torgeir Engstad, Ove Almkvist, Matti Viitanen, Egil Arnesen, Demosthenes B. Panagiotakos, Christina Chrysohoou, Christos Pitsavos, Alessandro Menotti, Anastasios Dontas, John Skoumas, Christodoulos Stefanadis, Pavlos Toutouzas, Amanda S. Persad, Todd Stedeford, Seigo Tanaka, Liping Chen, Marek Banasik, M. Alessandra Sotgiu, Charles M. Poser, Giulio Rosati, Ian Lawson - Neuroepidemiology 2003 cited by 645

  7. Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study

    Authors: Gísli Jenkins, Juliet K. Simpson, Gauri Saini, Jane H Bentley, Anne‐Marie Russell, Rebecca Braybrooke, Philip L. Molyneaux, Tricia M. McKeever, Athol U. Wells, Aiden Flynn, Richard Hubbard, Diana Julie Leeming, Richard P. Marshall, M.A. Karsdal, Pauline T. Lukey, Toby M. Maher - The Lancet Respiratory Medicine 2015 cited by 324

  8. Extracellular Matrix Cross-Linking Enhances Fibroblast Growth and Protects against Matrix Proteolysis in Lung Fibrosis

    Authors: Christopher J. Philp, Ivonne Siebeke, Debbie Clements, S. Miller, Anthony Habgood, Alison E. John, Vidya Navaratnam, Richard Hubbard, Gísli Jenkins, Simon R. Johnson - American Journal of Respiratory Cell and Molecular Biology 2017 cited by 161

  9. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care

    Authors: Johanna Feary, Laura C. Rodrigues, Christopher J. Smith, Richard Hubbard, Jack Gibson - Thorax 2010 cited by 447

  10. Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study

    Authors: Richard J. Allen, Joanne Porte, Rebecca Braybrooke, Carlos Flores, Tasha E. Fingerlin, Justin M. Oldham, Beatriz Guillén‐Guío, Shwu‐Fan Ma, Tsukasa Okamoto, Alison E. John, Ma’en Obeidat, Ivana V. Yang, Amanda P. Henry, Richard Hubbard, Vidya Navaratnam, Gauri Saini, Norma Thompson, Helen Booth, Simon P. Hart, Mike Hill, Nik Hirani, Toby M. Maher, Robin J. McAnulty, Ann Millar, Philip L. Molyneaux, Helen Parfrey, Doris M. Rassl, Moira K. B. Whyte, William A. Fahy, Richard P. Marshall, Eunice Oballa, Yohan Bossé, David C. Nickle, Don D. Sin, Wim Timens, Nick Shrine, Ian Sayers, Ian P. Hall, Imre Noth, David A. Schwartz, Martin D. Tobin, Louise V. Wain, Gísli Jenkins - The Lancet Respiratory Medicine 2017 cited by 300

  11. Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank

    Authors: Louise V. Wain, Nick Shrine, S. Miller, Victoria E. Jackson, Ioanna Ntalla, María Soler Artigas, Charlotte K. Billington, Abdul Kader Kheirallah, Richard J. Allen, James P. Cook, Kelly Probert, Ma’en Obeidat, Yohan Bossé, Ke Hao, Dirkje S. Postma, Peter D. Paré, Adaikalavan Ramasamy, Reedik Mägi, Evelin Mihailov, Eva Reinmaa, Erik Melén, Jared O’Connell, Eleni Frangou, Olivier Delaneau, Colin Freeman, Desislava Petkova, Mark I. McCarthy, Ian Sayers, Panos Deloukas, Richard Hubbard, Ian Pavord, Anna Hansell, Neil C. Thomson, Eleftheria Zeggini, Andrew P. Morris, Jonathan Marchini, David P. Strachan, Martin D. Tobin, Ian P. Hall - The Lancet Respiratory Medicine 2015 cited by 435

  12. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK

    Authors: Jonathan Gribbin, Richard Hubbard, Ivan Le Jeune, C. J. P. Smith, Joe West, Laila J. Tata - Thorax 2006 cited by 573

  13. The rising incidence of idiopathic pulmonary fibrosis in the UK

    Authors: Vidya Navaratnam, Kate M. Fleming, Joe West, C. J. P. Smith, Gísli Jenkins, A. Fogarty, Richard Hubbard - Thorax 2011 cited by 491

  14. Biomarker signatures for progressive idiopathic pulmonary fibrosis

    Authors: Britt Clynick, Tamera J. Corte, Helen E. Jo, Iain Stewart, Ian Glaspole, Christopher Grainge, Toby M. Maher, Vidya Navaratnam, Richard Hubbard, Peter Hopkins, Paul N. Reynolds, Sally Chapman, Christopher Zappala, Gregory J. Keir, Wendy A. Cooper, Annabelle Mahar, Samantha Ellis, Nicole Goh, Emma de Jong, Lilian Cha, Dino B.A. Tan, Lucy Leigh, Christopher Oldmeadow, E. Haydn Walters, Gísli Jenkins, Yuben Moodley - European Respiratory Journal 2021 cited by 85

  15. An intelligent early warning system of analyzing Twitter data using machine learning on COVID-19 surveillance in the US

    Authors: Yiming Zhang, Ke Chen, Ying Weng, Zhuo Chen, Juntao Zhang, Richard Hubbard - Expert Systems with Applications, Expert Syst. Appl. 2022 cited by 55

  16. Increasing Global Mortality from Idiopathic Pulmonary Fibrosis in the Twenty-First Century

    Authors: John Hutchinson, Tricia M. McKeever, Andrew Fogarty, Vidya Navaratnam, Richard Hubbard - Annals of the American Thoracic Society 2014 cited by 230

  17. Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study

    Authors: Richard J. Allen, Justin M. Oldham, David Jenkins, Olivia C. Leavy, Beatriz Guillén‐Guío, Carl Melbourne, Shwu‐Fan Ma, Jonathan Jou, John S. Kim, William A. Fahy, Eunice Oballa, Richard Hubbard, Vidya Navaratnam, Rebecca Braybrooke, Gauri Saini, Katy M. Roach, Martin D. Tobin, Nik Hirani, Moira K. B. Whyte, Naftali Kaminski, Yingze Zhang, Fernando J. Martínez, A. Linderholm, Ayodeji Adegunsoye, Mary E. Strek, Toby M. Maher, Philip L. Molyneaux, Carlos Flores, Imre Noth, Gísli Jenkins, Louise V. Wain - The Lancet Respiratory Medicine 2022 cited by 65

  18. Lung Cancer and Cryptogenic Fibrosing Alveolitis: A Population-based Cohort Study

    Authors: Richard Hubbard, Andrea Venn, Sarah Lewis, John Britton - American Journal of Respiratory and Critical Care Medicine 2000 cited by 641

  19. The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK

    Authors: Ivan Le Jeune, Jonathan Gribbin, Joe West, Chris Smith, Paul Cullinan, Richard Hubbard - Respiratory Medicine 2007 cited by 299

  20. Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis

    Authors: Emma Harknett, William Chang, S. Byrnes, Joyce T. Johnson, Romain Lazor, Marsha M. Cohen, Benjamin J Gray, S. Geiling, H. J. Telford, Anne E. Tattersfield, Richard Hubbard, Simon R. Johnson - QJM 2011 cited by 185

  21. Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma

    Authors: Celeste Porsbjerg, John Townend, Céline Bergeron, George Christoff, Gregory Katsoulotos, Désirée Larenas‐Linnemann, Trung N. Tran, Riyad Al‐Lehebi, Sinthia Bosnic‐Anticevich, John Busby, Mark Hew, Κonstantinos Κostikas, Nikolaos G. Papadopoulos, Paul Pfeffer, Todor A. Popov, Chin Kook Rhee, Mohsen Sadatsafavi, Ming‐Ju Tsai, Charlotte Suppli Ulrik, Mona Al‐Ahmad, Alan Altraja, Aaron Beastall, Lakmini Bulathsinhala, Victoria Carter, Borja G. Cosío, Kirsty Fletton, Susanne Hansen, Liam G. Heaney, Richard Hubbard, Piotr Kuna, Ruth Murray, Tatsuya Nagano, Laura Pini, Diana Jimena Cano Rosales, Florence Schleich, Michael E. Wechsler, Rita Amaral, Arnaud Bourdin, Guy Brusselle, Wenjia Chen, Li Ping Chung, Eve Denton, João Fonseca, Flavia Hoyte, David J. Jackson, Rohit Katial, Bruce Kirenga, Mariko Siyue Koh, Agnieszka Ławkiedraj, Lauri Lehtimäki, Mei Fong Liew, Bassam Mahboub, Neil Martin, Andrew Menzies‐Gow, Pee Hwee Pang, Andriana Ι. Papaioannou, Pujan H. Patel, Luis Pérez de Llano, Matthew Peters, L Ricciardi, Bellanid Rodríguez-Cáceres, Iván Solarte, Tunn Ren Tay, Carlos A. Torres‐Duque, Eileen Wang, Martina Zappa, John Abisheganaden, Karin Dahl Assing, Richard W. Costello, Peter G. Gibson, Enrico Heffler, Jorge Máspero, Stefania Nicola, Diahn‐Warng Perng, Francesca Puggioni, Sundeep Salvi, Chau‐Chyun Sheu, Concetta Sirena, Camille Taillé, Tze Lee Tan, Leif Bjermer, Giorgio Walter Canonica, Takashi Iwanaga, Libardo Jiménez-Maldonado, Christian Taube, Luisa Brussino, David Price - Frontiers in Immunology 2024 cited by 28

  22. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting

    Authors: Liam Smeeth, Claire Cook, Sara Thomas, Andrew J. Hall, Richard Hubbard, Patrick Vallance - The Lancet 2006 cited by 454

  23. Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997–2008

    Authors: John Hutchinson, Tricia M. McKeever, Andrew Fogarty, Vidya Navaratnam, Richard Hubbard - European Respiratory Journal 2016 cited by 168

  24. Bronchiectasis and the risk of cardiovascular disease: a population-based study

    Authors: Vidya Navaratnam, Elizabeth R. C. Millett, John R. Hurst, Sara L. Thomas, Liam Smeeth, Richard Hubbard, Jeremy Brown, Jennifer K Quint - Thorax 2016 cited by 99